The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Scoring model with serum albumin and CA19-9 in advanced pancreatic cancer in second-line treatment: Results from the NAPOLEON study.
 
Azusa Komori
No Relationships to Disclose
 
Satoshi Otsu
No Relationships to Disclose
 
Mototsugu Shimokawa
Consulting or Advisory Role - Sysmex; Sysmex; Sysmex; Sysmex
 
Taiga Otsuka
Stock and Other Ownership Interests - Eisai; Eisai; Eisai; Eisai
Research Funding - Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma
 
Futa Koga
No Relationships to Disclose
 
Yujiro Ueda
No Relationships to Disclose
 
Junichi Nakazawa
No Relationships to Disclose
 
Shiho Arima
No Relationships to Disclose
 
Masaru Fukahori
No Relationships to Disclose
 
Yoshinobu Okabe
No Relationships to Disclose
 
Akitaka Makiyama
Speakers' Bureau - Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Lilly; Lilly; Lilly; Lilly; Takeda; Takeda; Takeda; Takeda
 
Hiroki Taguchi
No Relationships to Disclose
 
Takuya Honda
No Relationships to Disclose
 
Taro Shibuki
No Relationships to Disclose
 
Kenta Nio
No Relationships to Disclose
 
Yasushi Ide
No Relationships to Disclose
 
Norio Ureshino
No Relationships to Disclose
 
Tsuyoshi Shirakawa
Consulting or Advisory Role - Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma
 
Kenji Mitsugi
No Relationships to Disclose